Drug Discovery World

 
Tags

REAL-TIME PCR - where we are and where are we heading

By Dr Mikael Kubista

Quantitative real-time PCR is becoming mature technology for the quantification of nucleic acids. It is spreading wide outside its original use in the research laboratories, becoming preferred technology for a range of applications, many that require specialised solutions and adaptations. Integration with pre-analytical steps and post-processing operations are becoming key challenges. more...

COMPOUND PROFILING size impact on primary screening libraries

By William Downey, Cindy Liu and Dr Jennifer Hartigan

A recent report examines the trends in utilisation of compound libraries, as well as the impact of profiling on the size of screening decks. The drivers for choosing between large or focused libraries may be different, but the ultimate goal remains the same: improve drug discovery. more...

The Microplate Market Past, Present and Future

By Dr Peter Banks

Microplates and the peripheral markets of liquid handling and detection technologies exist within almost all laboratories performing assays. This article discusses what, if any, are their growth expectations and whether there are new technologies on the horizon that could make the microplate obsolete. more...

Letting the Target Determine your Compound Acquisition Strategy

By Dr John Harris

With compound libraries likely to remain the cornerstone of hit and lead discovery for the foreseeable future, this paper seeks to summarise current and future approaches to optimal library design and compound acquisition, using examples and experimental evidence of the success, limitations and weaknesses of target-led approaches in comparison with diversity-screening alternatives. more...

Monochromator vs Filter-based Plate Readers; horses for courses, or a winning combination?

By Dr John Comley

This article is based around feedback obtained in HTStec’s recent Multi-Mode Microplate Reader Trends 2007 Report. more...

qPCR Assays; end user practices and latest vendor offerings

By Dr John Comley

This review provides an insight into real-time quantitative PCR (qPCR) assays today. more...

Of Mice and Men

By Dr Catherine A. Brady

The effort to develop drugs that interact with the human immune system (whether by accident or design) has been dogged by a mismatch between the data derived from animal models (mice in particular) and that found in man. more...

Emerging Real-time PCR applications

Dr Mikael Kubista

Since its introduction on the commercial market little more than 10 years ago, real-time PCR has become the main technical platform for nucleic acid
detection in research and development, as well as in routine diagnostics.
more...

21st century VACCINES a Development Renaissance

By Dr Jeff Stoddard, Charles Drucker and Dr Nigel Brown

Human beings have benefited from vaccines for more than two centuries. From eradicating some of the deadliest diseases to nearly eliminating a host of others, including polio, measles, mumps and tetanus – vaccines are one of the world’s greatest lifesavers. more...

Trends in the microRNA Marketplace

By Kathy Gray and Dr Enal Razvi

In this article, a recent market analysis is discussed aimed at understanding the market landscape, trends and opportunity in the rapidly-expanding microRNA marketplace. These market analyses are presented in detail in a recently published MicroRNA 2008 market report. more...

Next Generation DNA Sequencing Technologies

By Dr Bruce E. Taillon and Brendon Hill

Human genetics is the foundation of disease as well as the response to pharmaceutical agents. Today, promising drugs are abandoned due to the lack of significant efficacy in broad patient populations. Recently, blockbuster drugs have been removed from the market due to unexplained toxicity not revealed in clinical trials. more...

A Focus on Molecular Imaging

By Dr Ken Rubenstein

By combining cutting-edge biomedical research with the time-proven ability to visualise the unseen, the rapidly emerging field of molecular imaging promises to open new vistas for a wide range of individuals, from basic researchers to scientists working in drug discovery and development and to physicians in medical practice. more...

More Links:

SEARCH